News
a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, Ph.D., today announced an exclusive licensing agreement for IL-11 directed ...
Alphabet’s Calico Life Sciences is inking a deal worth up to $571 million biobucks for the rights to investigational IL-11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback